EJ

Epma Journal

EPMA Journal publishes results and achievements in primary care focused on individualised protection of healthy persons against health-to-disease transition and in secondary care focused on protection against disease progression. The journal emphasizes a paradigm change from reactive medicine to a cost-effective predictive approach, targeted prevention, and treatments tailored to the person, supported by multi-professional expertise, non-invasive diagnostics, innovative treatment algorithms, and technology development from bench to bedside. It is the official journal of the European Association for Predictive, Preventive and Personalized Medicine.

Looking to publish in Epma Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Impact Factor 5.9
Quartile Q1
Open Access Type Hybrid
ISSN 1878-5077
eISSN 1878-5085
Invitation Only No
Cost Range Open access APC: £2990.00 GBP / $4790.00 USD / €3790.00 EUR; subscription option: no APC charges apply.

Submission Instructions

Epma Journal accepts the following article types. Click on an article type to view submission instructions.

Position Paper

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 to 250 words. Manuscript must provide corresponding evidence-based statements in the Abstract, Introduction, Working hypothesis, and Conclusions and Outlook sections.
Manuscript Manuscript must include sections for Introduction, Working hypothesis, and Conclusions and Outlook. Submission must include an essential PPPM Innovation Highlights document structured around the working hypothesis in the framework of PPPM, innovation toward predictive approach, targeted prevention, and personalisation of medical services, and how the innovation goes beyond the state of the art contributing to the paradigm shift from reactive medicine to PPPM, and a disclosure statement is required.
References Citations must use numbered references in square brackets. Reference list entries must be numbered consecutively and include only works cited in the text that have been published or accepted for publication.
Figures & Tables Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions.
Reformat to Epma Journal using Livewrite Premium

Recent Publications

Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context

Vincenzo Tragni, Francesca Preziusi, Luna Laera, Angelo Onofrio, Ivan Mercurio, Simona Todisco, Mariateresa Volpicella, Anna De Grassi, Ciro Leonardo Pierri

10.1007/s13167-021-00267-w
View Publication

Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study

Xianglin Hu, Wending Huang, Zhengwang Sun, Hui Ye, Kwong Man, Qifeng Wang, Yangbai Sun, Wangjun Yan

10.1007/s13167-022-00270-9
View Publication

Development and validation of a transcriptomic signature-based model as the predictive, preventive, and personalized medical strategy for preterm birth within 7 days in threatened preterm labor women

Yuxin Ran, Jie He, Wei Peng, Zheng Liu, Youwen Mei, Yunqian Zhou, Nanlin Yin, Hongbo Qi

10.1007/s13167-021-00268-9
View Publication

Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach

Yu Yuan, Chenxin Yang, Yingzhi Wang, Mingming Sun, Chenghao Bi, Sitong Sun, Guijiang Sun, Jingpeng Hao, Lingling Li, Changliang Shan, Shuai Zhang, Yubo Li

10.1007/s13167-021-00269-8
View Publication

Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients

Julia Brunmair, Andrea Bileck, Doreen Schmidl, Gerhard Hagn, Samuel M. Meier-Menches, Nikolaus Hommer, Andreas Schlatter, Christopher Gerner, Gerhard Garhöfer

10.1007/s13167-022-00272-7
View Publication

Frequently asked questions

How long does it take to publish?

Articles are published online after receipt of the corrected proofs.

Reformat to Epma Journal using Livewrite Premium

Is a cover letter required?

A cover letter is used to mention any unpublished material included in the manuscript and may be used to suggest peer reviewers with institutional email addresses and ORCID or Scopus ID.

Reformat to Epma Journal using Livewrite Premium

What are the publication costs?

Open access APC is £2990.00 GBP / $4790.00 USD / €3790.00 EUR, subject to VAT or local taxes where applicable. Subscription publishing has no APC charges.

Reformat to Epma Journal using Livewrite Premium

Research Topics

Retinal Diseases and Treatments Glaucoma and retinal disorders Cardiovascular Health and Risk Factors Nutrition, Genetics, and Disease Retinal Imaging and Analysis Health, Environment, Cognitive Aging Gut microbiota and health Health Systems, Economic Evaluations, Quality of Life Ferroptosis and cancer prognosis Bioinformatics and Genomic Networks Cancer Genomics and Diagnostics Oral microbiology and periodontitis research Diabetes, Cardiovascular Risks, and Lipoproteins Diet and metabolism studies Computational Drug Discovery Methods Metabolomics and Mass Spectrometry Studies BRCA gene mutations in cancer Sleep and related disorders Nutritional Studies and Diet Genomics and Rare Diseases Healthcare Systems and Public Health Machine Learning in Healthcare Multiple Sclerosis Research Studies Blood Pressure and Hypertension Studies Liver Disease Diagnosis and Treatment